Delivery of substances and their target-specific topical activation

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 5, 2006, Pages 606-610

  Pipkorn, Rüdiger ^a   Waldeck, Waldemar ^a   Spring, Herbert ^a   Jenne, Jürgen W ^a   Braun, Klaus ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cathepsin B; Drug targeting; Glioblastoma multiforme; Intracellular targeting; Solid phase peptide synthesis; SPPS; Transmembrane transport

Indexed keywords

CATHEPSIN B; DRUG CARRIER; PEPTIDE;

ARTICLE; CANCER THERAPY; CELL MEMBRANE TRANSPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; ENZYME ACTIVE SITE; ENZYME DEGRADATION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

ADMINISTRATION, TOPICAL; AMINO ACID SEQUENCE; CATHEPSIN B; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; HUMANS; MICROSCOPY, CONFOCAL; SENSITIVITY AND SPECIFICITY;

EID: 33745263061     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.03.036     Document Type: Article

References (13)

1. Pipkorn R., Waldeck W., and Braun K. Synthesis and application of functional peptides as cell nucleus-directed molecules in the treatment of malignant diseases. J. Mol. Recognit. 16 (2003) 240-247
2. Blomer U., Ganser A., and Scherr M. Invasive drug delivery. Adv. Exp. Med. Biol. 513 (2002) 431-451
3. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
4. Braun K., Peschke P., Pipkorn R., Lampel S., Wachsmuth M., Waldeck W., Friedrich E., and Debus J. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J. Mol. Biol. 318 (2002) 237-243
5. Bankowska A., Gacko M., Chyczewska E., and Worowska A. Biological and diagnostic role of cathepsin D. Rocz. Akad. Med. Bialymst. 42 Suppl. 1 (1997) 79-85
6. Berquin I.M., and Sloane B.F. Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 389 (1996) 281-294
7. Merriefield R.B. Solid phase peptide synthesis. I The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85 (1963) 2149-2154
8. Carpino L.A., and Han G.Y. The 9-Fluorenylmethoxycarbonyl amino-protecting group. J. Org. Chem. 37 (1972) 3404-3409
9. Levicar N., Nuttall R.K., and Lah T.T. Proteases in brain tumour progression. Acta Neurochir. (Wien.) 145 (2003) 825-838
10. Keppler D., Sameni M., Moin K., Mikkelsen T., Diglio C.A., and Sloane B.F. Tumor progression and angiogenesis: cathepsin B and Co. Biochem. Cell Biol. 74 (1996) 799-810
11. Strojnik T., Zajc I., Bervar A., Zidanik B., Golouh R., Kos J., Dolenc V., and Lah T. Cathepsin B and its inhibitor stefin A in brain tumors. Pflugers Arch. 439 (2000) R122-R123
12. Buttle D.J., Murata M., Knight C.G., and Barrett A.J. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. Arch. Biochem. Biophys. 299 (1992) 377-380
13. Montaser M., Lalmanach G., and Mach L. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 383 (2002) 1305-1308